IT1293803B1 - Formulazioni di aerosol medicinali - Google Patents

Formulazioni di aerosol medicinali

Info

Publication number
IT1293803B1
IT1293803B1 IT97MI001798A ITMI971798A IT1293803B1 IT 1293803 B1 IT1293803 B1 IT 1293803B1 IT 97MI001798 A IT97MI001798 A IT 97MI001798A IT MI971798 A ITMI971798 A IT MI971798A IT 1293803 B1 IT1293803 B1 IT 1293803B1
Authority
IT
Italy
Prior art keywords
aerosol formulations
medicinal aerosol
medicinal
formulations
aerosol
Prior art date
Application number
IT97MI001798A
Other languages
English (en)
Italian (it)
Inventor
David Lewis
Davis Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1293803(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI971798A1 publication Critical patent/ITMI971798A1/it
Application granted granted Critical
Publication of IT1293803B1 publication Critical patent/IT1293803B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT97MI001798A 1997-06-13 1997-07-28 Formulazioni di aerosol medicinali IT1293803B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (2)

Publication Number Publication Date
ITMI971798A1 ITMI971798A1 (it) 1999-01-28
IT1293803B1 true IT1293803B1 (it) 1999-03-10

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001798A IT1293803B1 (it) 1997-06-13 1997-07-28 Formulazioni di aerosol medicinali

Country Status (45)

Country Link
EP (2) EP0920302B2 (ja)
JP (1) JP4380802B2 (ja)
KR (1) KR100546239B1 (ja)
CN (1) CN1138532C (ja)
AR (1) AR012977A1 (ja)
AT (1) ATE222751T1 (ja)
AU (1) AU729966B2 (ja)
BG (1) BG63906B1 (ja)
BR (1) BR9805993B1 (ja)
CA (1) CA2263445C (ja)
CO (1) CO4940408A1 (ja)
CZ (1) CZ295521B6 (ja)
DE (1) DE69807420T3 (ja)
DK (1) DK0920302T4 (ja)
DZ (1) DZ2516A1 (ja)
EA (1) EA001259B1 (ja)
EE (1) EE03664B1 (ja)
ES (1) ES2182351T5 (ja)
GB (1) GB2326334A (ja)
GE (1) GEP20012462B (ja)
HK (1) HK1022271A1 (ja)
HR (1) HRP980317B1 (ja)
HU (1) HU228487B1 (ja)
ID (1) ID21491A (ja)
IL (1) IL128484A (ja)
IN (1) IN189317B (ja)
IS (1) IS2435B (ja)
IT (1) IT1293803B1 (ja)
MA (1) MA26507A1 (ja)
ME (2) ME00333B (ja)
MY (1) MY119074A (ja)
NO (1) NO327775B1 (ja)
NZ (1) NZ334149A (ja)
PL (1) PL193721B1 (ja)
PT (1) PT920302E (ja)
RS (1) RS51274B (ja)
SA (1) SA98190821B1 (ja)
SI (1) SI0920302T2 (ja)
SK (1) SK284430B6 (ja)
TN (1) TNSN98087A1 (ja)
TR (1) TR199900288T1 (ja)
TW (1) TW555570B (ja)
UA (1) UA70289C2 (ja)
WO (1) WO1998056349A1 (ja)
ZA (1) ZA985136B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
EP1143930B8 (en) 1999-09-11 2008-03-19 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
ATE286716T1 (de) * 1999-11-23 2005-01-15 Glaxo Group Ltd Pharmazeutische formulierungen enthaltend salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
HU230804B1 (hu) * 2000-05-22 2018-06-28 Chiesi Farmaceutici S.P.A Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
GEP20063986B (en) 2002-03-01 2006-12-11 Chiesi Farma Spa Formoterol superfine formulation
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc FULLY HALOGENATED FLUOROCARBON HYDROGEN AND HYDROFLUOROCHLOROUS HYDROGEN FUELS AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
WO2004084858A2 (en) 2003-03-20 2004-10-07 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EA013428B1 (ru) 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
MX2010005036A (es) * 2007-11-07 2010-05-27 Astrazeneca Ab Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
CA2808245A1 (en) * 2010-09-06 2012-03-15 Chiesi Farmaceutici S.P.A. Metered-dose inhaler and method of using the same
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
WO2018051131A1 (en) * 2016-09-19 2018-03-22 Mexichem Fluor S.A. De C.V. Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863720A (en) † 1986-03-10 1989-09-05 Walter Burghart Pharmaceutical preparation and methods for its production
CA1293929C (en) † 1986-03-10 1992-01-07 Kurt Burghart Pharmaceutical composition containing nifedipine
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DK0553298T3 (da) † 1990-10-18 1995-04-18 Minnesota Mining & Mfg Aerosolformulering omfattende beclomethason-17,21-dipropionat
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
PT656207E (pt) † 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
EP1005860A1 (en) † 1991-06-10 2000-06-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
DE69233319T2 (de) * 1991-12-18 2005-02-17 Minnesota Mining & Manufacturing Company, St. Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
UA27143C2 (uk) * 1992-12-09 2000-02-28 Берінгер Інгельхейм Фармасьютікалс Інк Рідка фармацевтичhа композиція в формі аерозолю
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
WO1995031182A1 (en) † 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
KR20000069275A (ko) † 1996-12-04 2000-11-25 새들러 테리 아이언 약학 조성물과 그 투여를 위한 장치
PT1014943E (pt) † 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois

Also Published As

Publication number Publication date
EP1219293A3 (en) 2003-05-28
NO327775B1 (no) 2009-09-21
ITMI971798A1 (it) 1999-01-28
KR100546239B1 (ko) 2006-01-26
MEP44008A (en) 2011-02-10
HUP0001339A3 (en) 2000-10-30
DK0920302T3 (da) 2002-12-23
CA2263445A1 (en) 1998-12-17
NZ334149A (en) 2000-07-28
CN1229355A (zh) 1999-09-22
EP0920302A1 (en) 1999-06-09
SK284430B6 (sk) 2005-04-01
EA001259B1 (ru) 2000-12-25
IN189317B (ja) 2003-02-08
EE03664B1 (et) 2002-04-15
DE69807420T3 (de) 2006-11-16
CA2263445C (en) 2008-09-09
EA199900201A1 (ru) 1999-06-24
AR012977A1 (es) 2000-11-22
ID21491A (id) 1999-06-17
CO4940408A1 (es) 2000-07-24
EP0920302B2 (en) 2006-06-21
HUP0001339A2 (hu) 2000-09-28
AU729966B2 (en) 2001-02-15
SI0920302T1 (en) 2002-12-31
GEP20012462B (en) 2001-06-25
PT920302E (pt) 2002-11-29
PL193721B1 (pl) 2007-03-30
HK1022271A1 (en) 2000-08-04
EP1219293A2 (en) 2002-07-03
ZA985136B (en) 1999-01-07
ME00333B (me) 2011-02-10
IL128484A0 (en) 2000-01-31
YU6999A (sh) 2000-03-21
TR199900288T1 (xx) 1999-09-21
SA98190821B1 (ar) 2006-11-19
TNSN98087A1 (fr) 2005-03-15
IS2435B (is) 2008-10-15
EP0920302B1 (en) 2002-08-28
BG103221A (en) 1999-09-30
AU8626298A (en) 1998-12-30
ES2182351T3 (es) 2003-03-01
HRP980317B1 (en) 2002-06-30
BR9805993B1 (pt) 2009-05-05
KR20000068171A (ko) 2000-11-25
MY119074A (en) 2005-03-31
DE69807420D1 (de) 2002-10-02
BG63906B1 (bg) 2003-06-30
BR9805993A (pt) 1999-08-31
DZ2516A1 (fr) 2004-11-08
WO1998056349A1 (en) 1998-12-17
UA70289C2 (uk) 2004-10-15
HU228487B1 (en) 2013-03-28
ATE222751T1 (de) 2002-09-15
EE9900055A (et) 1999-08-16
ES2182351T5 (es) 2007-03-16
MA26507A1 (fr) 2004-12-20
TW555570B (en) 2003-10-01
CZ46299A3 (cs) 1999-07-14
SK17699A3 (en) 1999-07-12
HRP980317A2 (en) 1999-04-30
NO990594D0 (no) 1999-02-09
SI0920302T2 (sl) 2006-10-31
GB9712434D0 (en) 1997-08-13
IL128484A (en) 2004-09-27
IS4974A (is) 1999-02-11
JP4380802B2 (ja) 2009-12-09
PL331531A1 (en) 1999-07-19
NO990594L (no) 1999-04-13
DK0920302T4 (da) 2006-10-09
DE69807420T2 (de) 2003-05-08
RS51274B (sr) 2010-12-31
JP2000516965A (ja) 2000-12-19
CZ295521B6 (cs) 2005-08-17
CN1138532C (zh) 2004-02-18
GB2326334A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
IT1293803B1 (it) Formulazioni di aerosol medicinali
DE69530325D1 (de) Aerosol-arzneiformulierungen
DK1073417T3 (da) Farmaceutisk aerosolformulering
NO992339L (no) Farmasöytiske formuleringer
ID24654A (id) Formulasi farmasi omeprazola
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
GB9713149D0 (en) Pharmaceutical formulations
MA24473A1 (fr) Formulations
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
ID16781A (id) Formulasi-formulasi farmasi
DE69830154D1 (de) Pharmazeutische zusammensetzungen
ITMI941169A0 (it) Formulazioni farmaceutiche
EE200000330A (et) Farmatseutilised kompositsioonid
NO991430D0 (no) Insektfordrivende formuleringer
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
SE9404469D0 (sv) Aerosol formulations
SE9502452D0 (sv) Aerosol formulations
SE9404467D0 (sv) Drug formulations
GB9703607D0 (en) Pharmaceutical formulations
SE9502453D0 (sv) Drug formulations

Legal Events

Date Code Title Description
0001 Granted